Presentation PCI Outcomes 2014 Antiplatelet Therapy Before, During, and After PCI: Which One and How Long? Presenter: Dominick J. Angiolillo March 28, 2014
News Daily News Mortality Benefit with ACE Inhibitors in Nonobstructive CAD L.A. McKeown March 20, 2014
News Daily News FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications Yael L. Maxwell February 13, 2014
News Daily News Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario L.A. McKeown February 06, 2014
News Daily News Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy L.A. McKeown February 06, 2014
News Daily News Meta-analysis: Cumulative Stroke Higher with CABG vs. PCI; Late Stroke Comparable Yael L. Maxwell January 09, 2014
News Daily News Bioresorbable Scaffolds Show Promise in Select STEMI Patients Yael L. Maxwell January 09, 2014
News Daily News Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly December 30, 2013
News Conference News TCT 2013 Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias November 04, 2013
News Daily News SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion Leah Lawrence October 25, 2013
News Daily News Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI L.A. McKeown October 11, 2013
News Daily News Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina Caitlin E. Cox October 11, 2013
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013
Presentation Comparison of Dual vs. Triple Antiplatelet Therapy After DES According to Stent Length Presenter: S-W Lee September 26, 2013
News Conference News ESC 2013 Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013
News Conference News ESC 2013 TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS Caitlin E. Cox September 01, 2013
News Daily News Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin August 30, 2013
News Daily News TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events Yael L. Maxwell August 23, 2013